Global AI in Respiratory Diseases Supply, Demand and Key Producers, 2023-2029

December 2023 | 141 pages | ID: G21AF6E70A9DEN
GlobalInfoResearch

Abstracts

The global AI in Respiratory Diseases market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

This report studies the global AI in Respiratory Diseases demand, key companies, and key regions.

This report is a detailed and comprehensive analysis of the world market for AI in Respiratory Diseases, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of AI in Respiratory Diseases that contribute to its increasing demand across many markets.

Highlights and key features of the study

Global AI in Respiratory Diseases total market, 2018-2029, (USD Million)

Global AI in Respiratory Diseases total market by region & country, CAGR, 2018-2029, (USD Million)

U.S. VS China: AI in Respiratory Diseases total market, key domestic companies and share, (USD Million)

Global AI in Respiratory Diseases revenue by player and market share 2018-2023, (USD Million)

Global AI in Respiratory Diseases total market by Type, CAGR, 2018-2029, (USD Million)

Global AI in Respiratory Diseases total market by Application, CAGR, 2018-2029, (USD Million).

This reports profiles major players in the global AI in Respiratory Diseases market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include ArtiQ, Philips Healthcare, GE Healthcare, Siemens Healthineers, Swaasa AI, THIRONA, DeepMind Health, Verily and VIDA Diagnostics Inc, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World AI in Respiratory Diseases market.

Detailed Segmentation:

Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.

Global AI in Respiratory Diseases Market, By Region:

• United States
• China
• Europe
• Japan
• South Korea
• ASEAN
• India
• Rest of World

Global AI in Respiratory Diseases Market, Segmentation by Type

• Pulmonary Infection
• MRI
• CT Scan

Global AI in Respiratory Diseases Market, Segmentation by Application

• Hospital
• Diagnostic Centers
• Ambulatory Surgical Centers
• Others

Companies Profiled:

• ArtiQ
• Philips Healthcare
• GE Healthcare
• Siemens Healthineers
• Swaasa AI
• THIRONA
• DeepMind Health
• Verily
• VIDA Diagnostics Inc
• Icometrix
• Infervision
• PneumoWave
• Respiray
• Dectrocel Healthcare
• Zynnon

Key Questions Answered

1. How big is the global AI in Respiratory Diseases market?

2. What is the demand of the global AI in Respiratory Diseases market?

3. What is the year over year growth of the global AI in Respiratory Diseases market?

4. What is the total value of the global AI in Respiratory Diseases market?

5. Who are the major players in the global AI in Respiratory Diseases market?

Contents

1 SUPPLY SUMMARY

1.1 AI in Respiratory Diseases Introduction
1.2 World AI in Respiratory Diseases Market Size & Forecast (2018 & 2022 & 2029)
1.3 World AI in Respiratory Diseases Total Market by Region (by Headquarter Location)
  1.3.1 World AI in Respiratory Diseases Market Size by Region (2018-2029), (by Headquarter Location)
  1.3.2 United States AI in Respiratory Diseases Market Size (2018-2029)
  1.3.3 China AI in Respiratory Diseases Market Size (2018-2029)
  1.3.4 Europe AI in Respiratory Diseases Market Size (2018-2029)
  1.3.5 Japan AI in Respiratory Diseases Market Size (2018-2029)
  1.3.6 South Korea AI in Respiratory Diseases Market Size (2018-2029)
  1.3.7 ASEAN AI in Respiratory Diseases Market Size (2018-2029)
  1.3.8 India AI in Respiratory Diseases Market Size (2018-2029)
1.4 Market Drivers, Restraints and Trends
  1.4.1 AI in Respiratory Diseases Market Drivers
  1.4.2 Factors Affecting Demand
  1.4.3 AI in Respiratory Diseases Major Market Trends

2 DEMAND SUMMARY

2.1 World AI in Respiratory Diseases Consumption Value (2018-2029)
2.2 World AI in Respiratory Diseases Consumption Value by Region
  2.2.1 World AI in Respiratory Diseases Consumption Value by Region (2018-2023)
  2.2.2 World AI in Respiratory Diseases Consumption Value Forecast by Region (2024-2029)
2.3 United States AI in Respiratory Diseases Consumption Value (2018-2029)
2.4 China AI in Respiratory Diseases Consumption Value (2018-2029)
2.5 Europe AI in Respiratory Diseases Consumption Value (2018-2029)
2.6 Japan AI in Respiratory Diseases Consumption Value (2018-2029)
2.7 South Korea AI in Respiratory Diseases Consumption Value (2018-2029)
2.8 ASEAN AI in Respiratory Diseases Consumption Value (2018-2029)
2.9 India AI in Respiratory Diseases Consumption Value (2018-2029)

3 WORLD AI IN RESPIRATORY DISEASES COMPANIES COMPETITIVE ANALYSIS

3.1 World AI in Respiratory Diseases Revenue by Player (2018-2023)
3.2 Industry Rank and Concentration Rate (CR)
  3.2.1 Global AI in Respiratory Diseases Industry Rank of Major Players
  3.2.2 Global Concentration Ratios (CR4) for AI in Respiratory Diseases in 2022
  3.2.3 Global Concentration Ratios (CR8) for AI in Respiratory Diseases in 2022
3.3 AI in Respiratory Diseases Company Evaluation Quadrant
3.4 AI in Respiratory Diseases Market: Overall Company Footprint Analysis
  3.4.1 AI in Respiratory Diseases Market: Region Footprint
  3.4.2 AI in Respiratory Diseases Market: Company Product Type Footprint
  3.4.3 AI in Respiratory Diseases Market: Company Product Application Footprint
3.5 Competitive Environment
  3.5.1 Historical Structure of the Industry
  3.5.2 Barriers of Market Entry
  3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity

4 UNITED STATES VS CHINA VS REST OF THE WORLD (BY HEADQUARTER LOCATION)

4.1 United States VS China: AI in Respiratory Diseases Revenue Comparison (by Headquarter Location)
  4.1.1 United States VS China: AI in Respiratory Diseases Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
  4.1.2 United States VS China: AI in Respiratory Diseases Revenue Market Share Comparison (2018 & 2022 & 2029)
4.2 United States Based Companies VS China Based Companies: AI in Respiratory Diseases Consumption Value Comparison
  4.2.1 United States VS China: AI in Respiratory Diseases Consumption Value Comparison (2018 & 2022 & 2029)
  4.2.2 United States VS China: AI in Respiratory Diseases Consumption Value Market Share Comparison (2018 & 2022 & 2029)
4.3 United States Based AI in Respiratory Diseases Companies and Market Share, 2018-2023
  4.3.1 United States Based AI in Respiratory Diseases Companies, Headquarters (States, Country)
  4.3.2 United States Based Companies AI in Respiratory Diseases Revenue, (2018-2023)
4.4 China Based Companies AI in Respiratory Diseases Revenue and Market Share, 2018-2023
  4.4.1 China Based AI in Respiratory Diseases Companies, Company Headquarters (Province, Country)
  4.4.2 China Based Companies AI in Respiratory Diseases Revenue, (2018-2023)
4.5 Rest of World Based AI in Respiratory Diseases Companies and Market Share, 2018-2023
  4.5.1 Rest of World Based AI in Respiratory Diseases Companies, Headquarters (States, Country)
  4.5.2 Rest of World Based Companies AI in Respiratory Diseases Revenue, (2018-2023)

5 MARKET ANALYSIS BY TYPE

5.1 World AI in Respiratory Diseases Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
  5.2.1 Pulmonary Infection
  5.2.2 MRI
  5.2.3 CT Scan
5.3 Market Segment by Type
  5.3.1 World AI in Respiratory Diseases Market Size by Type (2018-2023)
  5.3.2 World AI in Respiratory Diseases Market Size by Type (2024-2029)
  5.3.3 World AI in Respiratory Diseases Market Size Market Share by Type (2018-2029)

6 MARKET ANALYSIS BY APPLICATION

6.1 World AI in Respiratory Diseases Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
  6.2.1 Hospital
  6.2.2 Diagnostic Centers
  6.2.3 Ambulatory Surgical Centers
  6.2.4 Others
  6.2.5 Others
6.3 Market Segment by Application
  6.3.1 World AI in Respiratory Diseases Market Size by Application (2018-2023)
  6.3.2 World AI in Respiratory Diseases Market Size by Application (2024-2029)
  6.3.3 World AI in Respiratory Diseases Market Size by Application (2018-2029)

7 COMPANY PROFILES

7.1 ArtiQ
  7.1.1 ArtiQ Details
  7.1.2 ArtiQ Major Business
  7.1.3 ArtiQ AI in Respiratory Diseases Product and Services
  7.1.4 ArtiQ AI in Respiratory Diseases Revenue, Gross Margin and Market Share (2018-2023)
  7.1.5 ArtiQ Recent Developments/Updates
  7.1.6 ArtiQ Competitive Strengths & Weaknesses
7.2 Philips Healthcare
  7.2.1 Philips Healthcare Details
  7.2.2 Philips Healthcare Major Business
  7.2.3 Philips Healthcare AI in Respiratory Diseases Product and Services
  7.2.4 Philips Healthcare AI in Respiratory Diseases Revenue, Gross Margin and Market Share (2018-2023)
  7.2.5 Philips Healthcare Recent Developments/Updates
  7.2.6 Philips Healthcare Competitive Strengths & Weaknesses
7.3 GE Healthcare
  7.3.1 GE Healthcare Details
  7.3.2 GE Healthcare Major Business
  7.3.3 GE Healthcare AI in Respiratory Diseases Product and Services
  7.3.4 GE Healthcare AI in Respiratory Diseases Revenue, Gross Margin and Market Share (2018-2023)
  7.3.5 GE Healthcare Recent Developments/Updates
  7.3.6 GE Healthcare Competitive Strengths & Weaknesses
7.4 Siemens Healthineers
  7.4.1 Siemens Healthineers Details
  7.4.2 Siemens Healthineers Major Business
  7.4.3 Siemens Healthineers AI in Respiratory Diseases Product and Services
  7.4.4 Siemens Healthineers AI in Respiratory Diseases Revenue, Gross Margin and Market Share (2018-2023)
  7.4.5 Siemens Healthineers Recent Developments/Updates
  7.4.6 Siemens Healthineers Competitive Strengths & Weaknesses
7.5 Swaasa AI
  7.5.1 Swaasa AI Details
  7.5.2 Swaasa AI Major Business
  7.5.3 Swaasa AI AI in Respiratory Diseases Product and Services
  7.5.4 Swaasa AI AI in Respiratory Diseases Revenue, Gross Margin and Market Share (2018-2023)
  7.5.5 Swaasa AI Recent Developments/Updates
  7.5.6 Swaasa AI Competitive Strengths & Weaknesses
7.6 THIRONA
  7.6.1 THIRONA Details
  7.6.2 THIRONA Major Business
  7.6.3 THIRONA AI in Respiratory Diseases Product and Services
  7.6.4 THIRONA AI in Respiratory Diseases Revenue, Gross Margin and Market Share (2018-2023)
  7.6.5 THIRONA Recent Developments/Updates
  7.6.6 THIRONA Competitive Strengths & Weaknesses
7.7 DeepMind Health
  7.7.1 DeepMind Health Details
  7.7.2 DeepMind Health Major Business
  7.7.3 DeepMind Health AI in Respiratory Diseases Product and Services
  7.7.4 DeepMind Health AI in Respiratory Diseases Revenue, Gross Margin and Market Share (2018-2023)
  7.7.5 DeepMind Health Recent Developments/Updates
  7.7.6 DeepMind Health Competitive Strengths & Weaknesses
7.8 Verily
  7.8.1 Verily Details
  7.8.2 Verily Major Business
  7.8.3 Verily AI in Respiratory Diseases Product and Services
  7.8.4 Verily AI in Respiratory Diseases Revenue, Gross Margin and Market Share (2018-2023)
  7.8.5 Verily Recent Developments/Updates
  7.8.6 Verily Competitive Strengths & Weaknesses
7.9 VIDA Diagnostics Inc
  7.9.1 VIDA Diagnostics Inc Details
  7.9.2 VIDA Diagnostics Inc Major Business
  7.9.3 VIDA Diagnostics Inc AI in Respiratory Diseases Product and Services
  7.9.4 VIDA Diagnostics Inc AI in Respiratory Diseases Revenue, Gross Margin and Market Share (2018-2023)
  7.9.5 VIDA Diagnostics Inc Recent Developments/Updates
  7.9.6 VIDA Diagnostics Inc Competitive Strengths & Weaknesses
7.10 Icometrix
  7.10.1 Icometrix Details
  7.10.2 Icometrix Major Business
  7.10.3 Icometrix AI in Respiratory Diseases Product and Services
  7.10.4 Icometrix AI in Respiratory Diseases Revenue, Gross Margin and Market Share (2018-2023)
  7.10.5 Icometrix Recent Developments/Updates
  7.10.6 Icometrix Competitive Strengths & Weaknesses
7.11 Infervision
  7.11.1 Infervision Details
  7.11.2 Infervision Major Business
  7.11.3 Infervision AI in Respiratory Diseases Product and Services
  7.11.4 Infervision AI in Respiratory Diseases Revenue, Gross Margin and Market Share (2018-2023)
  7.11.5 Infervision Recent Developments/Updates
  7.11.6 Infervision Competitive Strengths & Weaknesses
7.12 PneumoWave
  7.12.1 PneumoWave Details
  7.12.2 PneumoWave Major Business
  7.12.3 PneumoWave AI in Respiratory Diseases Product and Services
  7.12.4 PneumoWave AI in Respiratory Diseases Revenue, Gross Margin and Market Share (2018-2023)
  7.12.5 PneumoWave Recent Developments/Updates
  7.12.6 PneumoWave Competitive Strengths & Weaknesses
7.13 Respiray
  7.13.1 Respiray Details
  7.13.2 Respiray Major Business
  7.13.3 Respiray AI in Respiratory Diseases Product and Services
  7.13.4 Respiray AI in Respiratory Diseases Revenue, Gross Margin and Market Share (2018-2023)
  7.13.5 Respiray Recent Developments/Updates
  7.13.6 Respiray Competitive Strengths & Weaknesses
7.14 Dectrocel Healthcare
  7.14.1 Dectrocel Healthcare Details
  7.14.2 Dectrocel Healthcare Major Business
  7.14.3 Dectrocel Healthcare AI in Respiratory Diseases Product and Services
  7.14.4 Dectrocel Healthcare AI in Respiratory Diseases Revenue, Gross Margin and Market Share (2018-2023)
  7.14.5 Dectrocel Healthcare Recent Developments/Updates
  7.14.6 Dectrocel Healthcare Competitive Strengths & Weaknesses
7.15 Zynnon
  7.15.1 Zynnon Details
  7.15.2 Zynnon Major Business
  7.15.3 Zynnon AI in Respiratory Diseases Product and Services
  7.15.4 Zynnon AI in Respiratory Diseases Revenue, Gross Margin and Market Share (2018-2023)
  7.15.5 Zynnon Recent Developments/Updates
  7.15.6 Zynnon Competitive Strengths & Weaknesses

8 INDUSTRY CHAIN ANALYSIS

8.1 AI in Respiratory Diseases Industry Chain
8.2 AI in Respiratory Diseases Upstream Analysis
8.3 AI in Respiratory Diseases Midstream Analysis
8.4 AI in Respiratory Diseases Downstream Analysis

9 RESEARCH FINDINGS AND CONCLUSION

10 APPENDIX

10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. World AI in Respiratory Diseases Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
Table 2. World AI in Respiratory Diseases Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
Table 3. World AI in Respiratory Diseases Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
Table 4. World AI in Respiratory Diseases Revenue Market Share by Region (2018-2023), (by Headquarter Location)
Table 5. World AI in Respiratory Diseases Revenue Market Share by Region (2024-2029), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World AI in Respiratory Diseases Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
Table 8. World AI in Respiratory Diseases Consumption Value by Region (2018-2023) & (USD Million)
Table 9. World AI in Respiratory Diseases Consumption Value Forecast by Region (2024-2029) & (USD Million)
Table 10. World AI in Respiratory Diseases Revenue by Player (2018-2023) & (USD Million)
Table 11. Revenue Market Share of Key AI in Respiratory Diseases Players in 2022
Table 12. World AI in Respiratory Diseases Industry Rank of Major Player, Based on Revenue in 2022
Table 13. Global AI in Respiratory Diseases Company Evaluation Quadrant
Table 14. Head Office of Key AI in Respiratory Diseases Player
Table 15. AI in Respiratory Diseases Market: Company Product Type Footprint
Table 16. AI in Respiratory Diseases Market: Company Product Application Footprint
Table 17. AI in Respiratory Diseases Mergers & Acquisitions Activity
Table 18. United States VS China AI in Respiratory Diseases Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 19. United States VS China AI in Respiratory Diseases Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 20. United States Based AI in Respiratory Diseases Companies, Headquarters (States, Country)
Table 21. United States Based Companies AI in Respiratory Diseases Revenue, (2018-2023) & (USD Million)
Table 22. United States Based Companies AI in Respiratory Diseases Revenue Market Share (2018-2023)
Table 23. China Based AI in Respiratory Diseases Companies, Headquarters (Province, Country)
Table 24. China Based Companies AI in Respiratory Diseases Revenue, (2018-2023) & (USD Million)
Table 25. China Based Companies AI in Respiratory Diseases Revenue Market Share (2018-2023)
Table 26. Rest of World Based AI in Respiratory Diseases Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies AI in Respiratory Diseases Revenue, (2018-2023) & (USD Million)
Table 28. Rest of World Based Companies AI in Respiratory Diseases Revenue Market Share (2018-2023)
Table 29. World AI in Respiratory Diseases Market Size by Type, (USD Million), 2018 & 2022 & 2029
Table 30. World AI in Respiratory Diseases Market Size by Type (2018-2023) & (USD Million)
Table 31. World AI in Respiratory Diseases Market Size by Type (2024-2029) & (USD Million)
Table 32. World AI in Respiratory Diseases Market Size by Application, (USD Million), 2018 & 2022 & 2029
Table 33. World AI in Respiratory Diseases Market Size by Application (2018-2023) & (USD Million)
Table 34. World AI in Respiratory Diseases Market Size by Application (2024-2029) & (USD Million)
Table 35. ArtiQ Basic Information, Area Served and Competitors
Table 36. ArtiQ Major Business
Table 37. ArtiQ AI in Respiratory Diseases Product and Services
Table 38. ArtiQ AI in Respiratory Diseases Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 39. ArtiQ Recent Developments/Updates
Table 40. ArtiQ Competitive Strengths & Weaknesses
Table 41. Philips Healthcare Basic Information, Area Served and Competitors
Table 42. Philips Healthcare Major Business
Table 43. Philips Healthcare AI in Respiratory Diseases Product and Services
Table 44. Philips Healthcare AI in Respiratory Diseases Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 45. Philips Healthcare Recent Developments/Updates
Table 46. Philips Healthcare Competitive Strengths & Weaknesses
Table 47. GE Healthcare Basic Information, Area Served and Competitors
Table 48. GE Healthcare Major Business
Table 49. GE Healthcare AI in Respiratory Diseases Product and Services
Table 50. GE Healthcare AI in Respiratory Diseases Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 51. GE Healthcare Recent Developments/Updates
Table 52. GE Healthcare Competitive Strengths & Weaknesses
Table 53. Siemens Healthineers Basic Information, Area Served and Competitors
Table 54. Siemens Healthineers Major Business
Table 55. Siemens Healthineers AI in Respiratory Diseases Product and Services
Table 56. Siemens Healthineers AI in Respiratory Diseases Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 57. Siemens Healthineers Recent Developments/Updates
Table 58. Siemens Healthineers Competitive Strengths & Weaknesses
Table 59. Swaasa AI Basic Information, Area Served and Competitors
Table 60. Swaasa AI Major Business
Table 61. Swaasa AI AI in Respiratory Diseases Product and Services
Table 62. Swaasa AI AI in Respiratory Diseases Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 63. Swaasa AI Recent Developments/Updates
Table 64. Swaasa AI Competitive Strengths & Weaknesses
Table 65. THIRONA Basic Information, Area Served and Competitors
Table 66. THIRONA Major Business
Table 67. THIRONA AI in Respiratory Diseases Product and Services
Table 68. THIRONA AI in Respiratory Diseases Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 69. THIRONA Recent Developments/Updates
Table 70. THIRONA Competitive Strengths & Weaknesses
Table 71. DeepMind Health Basic Information, Area Served and Competitors
Table 72. DeepMind Health Major Business
Table 73. DeepMind Health AI in Respiratory Diseases Product and Services
Table 74. DeepMind Health AI in Respiratory Diseases Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 75. DeepMind Health Recent Developments/Updates
Table 76. DeepMind Health Competitive Strengths & Weaknesses
Table 77. Verily Basic Information, Area Served and Competitors
Table 78. Verily Major Business
Table 79. Verily AI in Respiratory Diseases Product and Services
Table 80. Verily AI in Respiratory Diseases Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 81. Verily Recent Developments/Updates
Table 82. Verily Competitive Strengths & Weaknesses
Table 83. VIDA Diagnostics Inc Basic Information, Area Served and Competitors
Table 84. VIDA Diagnostics Inc Major Business
Table 85. VIDA Diagnostics Inc AI in Respiratory Diseases Product and Services
Table 86. VIDA Diagnostics Inc AI in Respiratory Diseases Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 87. VIDA Diagnostics Inc Recent Developments/Updates
Table 88. VIDA Diagnostics Inc Competitive Strengths & Weaknesses
Table 89. Icometrix Basic Information, Area Served and Competitors
Table 90. Icometrix Major Business
Table 91. Icometrix AI in Respiratory Diseases Product and Services
Table 92. Icometrix AI in Respiratory Diseases Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 93. Icometrix Recent Developments/Updates
Table 94. Icometrix Competitive Strengths & Weaknesses
Table 95. Infervision Basic Information, Area Served and Competitors
Table 96. Infervision Major Business
Table 97. Infervision AI in Respiratory Diseases Product and Services
Table 98. Infervision AI in Respiratory Diseases Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 99. Infervision Recent Developments/Updates
Table 100. Infervision Competitive Strengths & Weaknesses
Table 101. PneumoWave Basic Information, Area Served and Competitors
Table 102. PneumoWave Major Business
Table 103. PneumoWave AI in Respiratory Diseases Product and Services
Table 104. PneumoWave AI in Respiratory Diseases Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 105. PneumoWave Recent Developments/Updates
Table 106. PneumoWave Competitive Strengths & Weaknesses
Table 107. Respiray Basic Information, Area Served and Competitors
Table 108. Respiray Major Business
Table 109. Respiray AI in Respiratory Diseases Product and Services
Table 110. Respiray AI in Respiratory Diseases Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 111. Respiray Recent Developments/Updates
Table 112. Respiray Competitive Strengths & Weaknesses
Table 113. Dectrocel Healthcare Basic Information, Area Served and Competitors
Table 114. Dectrocel Healthcare Major Business
Table 115. Dectrocel Healthcare AI in Respiratory Diseases Product and Services
Table 116. Dectrocel Healthcare AI in Respiratory Diseases Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 117. Dectrocel Healthcare Recent Developments/Updates
Table 118. Zynnon Basic Information, Area Served and Competitors
Table 119. Zynnon Major Business
Table 120. Zynnon AI in Respiratory Diseases Product and Services
Table 121. Zynnon AI in Respiratory Diseases Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 122. Global Key Players of AI in Respiratory Diseases Upstream (Raw Materials)
Table 123. AI in Respiratory Diseases Typical Customers

LIST OF FIGURE

Figure 1. AI in Respiratory Diseases Picture
Figure 2. World AI in Respiratory Diseases Total Market Size: 2018 & 2022 & 2029, (USD Million)
Figure 3. World AI in Respiratory Diseases Total Market Size (2018-2029) & (USD Million)
Figure 4. World AI in Respiratory Diseases Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
Figure 5. World AI in Respiratory Diseases Revenue Market Share by Region (2018-2029), (by Headquarter Location)
Figure 6. United States Based Company AI in Respiratory Diseases Revenue (2018-2029) & (USD Million)
Figure 7. China Based Company AI in Respiratory Diseases Revenue (2018-2029) & (USD Million)
Figure 8. Europe Based Company AI in Respiratory Diseases Revenue (2018-2029) & (USD Million)
Figure 9. Japan Based Company AI in Respiratory Diseases Revenue (2018-2029) & (USD Million)
Figure 10. South Korea Based Company AI in Respiratory Diseases Revenue (2018-2029) & (USD Million)
Figure 11. ASEAN Based Company AI in Respiratory Diseases Revenue (2018-2029) & (USD Million)
Figure 12. India Based Company AI in Respiratory Diseases Revenue (2018-2029) & (USD Million)
Figure 13. AI in Respiratory Diseases Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World AI in Respiratory Diseases Consumption Value (2018-2029) & (USD Million)
Figure 16. World AI in Respiratory Diseases Consumption Value Market Share by Region (2018-2029)
Figure 17. United States AI in Respiratory Diseases Consumption Value (2018-2029) & (USD Million)
Figure 18. China AI in Respiratory Diseases Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe AI in Respiratory Diseases Consumption Value (2018-2029) & (USD Million)
Figure 20. Japan AI in Respiratory Diseases Consumption Value (2018-2029) & (USD Million)
Figure 21. South Korea AI in Respiratory Diseases Consumption Value (2018-2029) & (USD Million)
Figure 22. ASEAN AI in Respiratory Diseases Consumption Value (2018-2029) & (USD Million)
Figure 23. India AI in Respiratory Diseases Consumption Value (2018-2029) & (USD Million)
Figure 24. Producer Shipments of AI in Respiratory Diseases by Player Revenue ($MM) and Market Share (%): 2022
Figure 25. Global Four-firm Concentration Ratios (CR4) for AI in Respiratory Diseases Markets in 2022
Figure 26. Global Four-firm Concentration Ratios (CR8) for AI in Respiratory Diseases Markets in 2022
Figure 27. United States VS China: AI in Respiratory Diseases Revenue Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: AI in Respiratory Diseases Consumption Value Market Share Comparison (2018 & 2022 & 2029)
Figure 29. World AI in Respiratory Diseases Market Size by Type, (USD Million), 2018 & 2022 & 2029
Figure 30. World AI in Respiratory Diseases Market Size Market Share by Type in 2022
Figure 31. Pulmonary Infection
Figure 32. MRI
Figure 33. CT Scan
Figure 34. World AI in Respiratory Diseases Market Size Market Share by Type (2018-2029)
Figure 35. World AI in Respiratory Diseases Market Size by Application, (USD Million), 2018 & 2022 & 2029
Figure 36. World AI in Respiratory Diseases Market Size Market Share by Application in 2022
Figure 37. Hospital
Figure 38. Diagnostic Centers
Figure 39. Ambulatory Surgical Centers
Figure 40. Others
Figure 41. AI in Respiratory Diseases Industrial Chain
Figure 42. Methodology
Figure 43. Research Process and Data Source